Searching for the ideal inotropic agent to rescue a failing heart

Cardiovascular Research

Volumn 91, Issue 3, 2011, Pages 371-372

  Howlett, Susan E ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [3 [N (3,4 DIMETHOXYPHENETHYL) N METHYLAMINO]PROPOXY]BENZENESULFONYL] 3 ISOPROPYL 1 METHYLINDOLE; CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; INOTROPIC AGENT; PHOSPHOLAMBAN; TROPONIN I;

CALCIUM CURRENT; CALCIUM HOMEOSTASIS; DRUG MECHANISM; ECHOCARDIOGRAPHY; EDITORIAL; ENZYME ACTIVITY; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE CELL; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; CARDIOTONIC AGENTS; HEART FAILURE; INDOLES; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; SULFONES;

EID: 79960759579     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr164     Document Type: Editorial

References (15)

1. Roger VL. The heart failure epidemic. Int J Environ Res Public Health 2010;7: 1807-1830.
2. Parissis JT, Farmakis D, Nieminen M. Classical inotropes and new cardiac enhancers. Heart Fail Rev 2007;12:149-156. (Pubitemid 46916961)
3. Toma M, Starling RC. Inotropic therapy for end-stage heart failure patients. Curr Treat Options Cardiovasc Med 2010;12:409-419.
4. Lehnart SE, Maier LS, Hasenfuss G. Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail Rev 2009;14: 213-224.
5. 2+ sensitizers-update 2001. Cardiovasc Drugs Ther 2001;15:397-403. (Pubitemid 34098510)
6. Perrone SV, Kaplinsky EJ. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure. Int J Cardiol 2005;103: 248-255. (Pubitemid 41132591)
7. Milligan DJ, Fields AM. Levosimendan: calcium sensitizer and inodilator. Anesthesiol Clin 2010;28:753-760.
8. Ait Mou Y, Toth A, Cassan C, Czuriga D, de Tombe PP, Papp Z et al. Beneficial effects of SR33805 in failing myocardium. Cardiovasc Res 2011;91:412-419.
9. 2+-sensitizing properties in cardiac myocytes. Br J Pharmacol 2003;139:99-108. (Pubitemid 36645313)
10. Aït Mou Y, Reboul C, Andre L, Lacampagne A, Cazorla O. Late exercise training improves non-uniformity of transmural myocardial function in rats with ischaemic heart failure. Cardiovasc Res 2009;81:555-564.
11. Wittköpper K, Dobrev D, Eschenhagen T, El-Armouche A. Phosphatase-1 inhibitor-1 in physiological and pathological β-adrenoceptor signalling. Cardiovasc Res 2011;91: 392-401.
12. Bers DM, Harris SP. Translational medicine: to the rescue of the failing heart. Nature 2011;473:36-39.
13. Ferrier GR, Howlett SE. Pretreatment with pinacidil promotes arrhythmias in an isolated tissue model of cardiac ischemia and reperfusion. J Pharmacol Exp Ther 2005;313: 823-830. (Pubitemid 40604184)
14. Ross JL, Howlett SE. Beta-adrenoceptor stimulation exacerbates detrimental effects of ischemia and reperfusion in isolated guinea pig ventricular myocytes. Eur J Pharmacol 2009;602:364-372.
15. Howlett SE. Age-associated changes in excitation-contraction coupling are more prominent in ventricular myocytes from male rats than in myocytes from female rats. Am J Physiol Heart Circ Physiol 2010;298:H659-670.